Your browser doesn't support javascript.
loading
BP­1­102 exerts antitumor effects on T­cell acute lymphoblastic leukemia cells by suppressing the JAK2/STAT3/c­Myc signaling pathway.
Ye, Can; Ruan, Xueqin; Zhao, Yan; Zhu, Hongkai; Wang, Canfei; Cheng, Zhao; Peng, Hongling.
Afiliação
  • Ye C; Department of Hematology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410000, P.R. China.
  • Ruan X; Institute of Molecular Hematology, Central South University, Changsha, Hunan 410000, P.R. China.
  • Zhao Y; Hunan Engineering Research Center of Targeted Therapy for Hematopoietic Malignancies, Changsha, Hunan 410000, P.R. China.
  • Zhu H; Department of Hematology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410000, P.R. China.
  • Wang C; Institute of Molecular Hematology, Central South University, Changsha, Hunan 410000, P.R. China.
  • Cheng Z; Hunan Engineering Research Center of Targeted Therapy for Hematopoietic Malignancies, Changsha, Hunan 410000, P.R. China.
  • Peng H; Department of Hematology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410000, P.R. China.
Exp Ther Med ; 25(5): 191, 2023 May.
Article em En | MEDLINE | ID: mdl-37020528
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Exp Ther Med Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Exp Ther Med Ano de publicação: 2023 Tipo de documento: Article